STRONG TOGETHER NETWORK
Live / Registered — Registered (as of 15 Sept 2026)
What this means for you
Registered since 15 Sept 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99116499
- Registration number
- 8442538
- Mark type
- Stylized text
- Filed
- 02 Apr 2025
- Published for opposition
- 14 Oct 2025
- Registered
- 15 Sept 2026
- Attorney of record
- Nels T. Lippert
Goods and services
- Class 041 — Education and entertainment services: Providing training in the field of sharing personal experiences with having and receiving treatment for recessive dystrophic epidermolysis bullosa (RDEB) as a patient and as a caregiver
- Class 042 — Scientific and technological services: Providing a website featuring technology that enables patients and caregivers to share information about recessive dystrophic epidermolysis bullosa (RDEB) and its treatment
- Class 044 — Medical, beauty and agricultural services: Providing medical information for patients and caregivers in the field of recessive dystrophic epidermolysis bullosa (RDEB) and its treatment via a website
Owner
- Abeona Therapeutics Inc., Cleveland, OH, US
- Abeona Therapeutics Inc., Cleveland, OH, US
- Abeona Therapeutics Inc., Cleveland, OH, US
Prosecution history
- 15 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 24 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Jul 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 20 May 2026 — USE AMENDMENT FILED
- 24 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 May 2026 — TEAS STATEMENT OF USE RECEIVED
- 09 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Oct 2025 — PUBLISHED FOR OPPOSITION
- 08 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED